Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma ...Middle East

- News
Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma
Patients with high-risk melanoma who had a course of pembrolizumab after their surgery had a longer time before their disease recurred than patients who got either ipilimumab or high-dose interferon after surgery. These findings of a large SWOG Cancer Research Network clinical trial, S1404, will be presented at the ASCO annual meeting June 6, 2021.

Hence then, the article about immune therapy after surgery lowers relapse risk in patients with high risk melanoma was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News